Sutro Biopharma (STRO) Capital Expenditures Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) Capital Expenditures Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -27.93% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -92.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -92.40% |
| Sep 30, 2025 | 382.89% |
| Jun 30, 2025 | -100.53% |
| Mar 31, 2025 | -93.95% |
| Dec 31, 2024 | 2,243.36% |
| Sep 30, 2024 | 76.30% |
| Jun 30, 2024 | -52.87% |
| Mar 31, 2024 | -52.65% |
| Dec 31, 2023 | 92.44% |
| Sep 30, 2023 | -12.18% |
| Jun 30, 2023 | -44.15% |
| Mar 31, 2023 | 6.92% |
| Dec 31, 2022 | -111.36% |
| Sep 30, 2022 | -350.70% |
| Jun 30, 2022 | 406.53% |
| Mar 31, 2022 | 8.90% |
| Dec 31, 2021 | 709.72% |
| Sep 30, 2021 | -73.48% |
| Jun 30, 2021 | -75.07% |
| Mar 31, 2021 | 217.25% |